227 related articles for article (PubMed ID: 22726823)
1. Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
Mogi M; Horiuchi M
Geriatr Gerontol Int; 2013 Jan; 13(1):13-8. PubMed ID: 22726823
[TBL] [Abstract][Full Text] [Related]
2. Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage.
Min LJ; Mogi M; Tsukuda K; Jing F; Ohshima K; Nakaoka H; Kan-No H; Wang XL; Chisaka T; Bai HY; Iwanami J; Horiuchi M
Am J Hypertens; 2014 Aug; 27(8):1036-44. PubMed ID: 24572705
[TBL] [Abstract][Full Text] [Related]
3. Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice.
Iwanami J; Mogi M; Tsukuda K; Jing F; Ohshima K; Wang XL; Nakaoka H; Kan-no H; Chisaka T; Bai HY; Min LJ; Horiuchi M
Eur J Pharmacol; 2014 Feb; 724():9-15. PubMed ID: 24361310
[TBL] [Abstract][Full Text] [Related]
4. The role of the central renin-angiotensin system in Parkinson's disease.
Mertens B; Vanderheyden P; Michotte Y; Sarre S
J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):49-56. PubMed ID: 19861346
[TBL] [Abstract][Full Text] [Related]
5. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.
Iwai M; Liu HW; Chen R; Ide A; Okamoto S; Hata R; Sakanaka M; Shiuchi T; Horiuchi M
Circulation; 2004 Aug; 110(7):843-8. PubMed ID: 15289370
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism.
Tota S; Nath C; Najmi AK; Shukla R; Hanif K
Behav Brain Res; 2012 Jun; 232(1):66-76. PubMed ID: 22460064
[TBL] [Abstract][Full Text] [Related]
7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
8. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
[TBL] [Abstract][Full Text] [Related]
9. Presence and physiologic function of the renin-angiotensin system in mouse lacrimal gland.
Yaguchi S; Ogawa Y; Shimmura S; Hatou S; Nakamura S; Inaba T; Imada T; Ozawa Y; Kawakami Y; Ishida S; Tsubota K
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5416-25. PubMed ID: 22786901
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
Ovbiagele B; Kidwell CS; Starkman S; Selco SL; Rajajee V; Razinia T; Saver JL
Neurology; 2005 Sep; 65(6):851-4. PubMed ID: 16186522
[TBL] [Abstract][Full Text] [Related]
11. The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases.
Fraga-Silva RA; Da Silva DG; Montecucco F; Mach F; Stergiopulos N; da Silva RF; Santos RA
Thromb Haemost; 2012 Dec; 108(6):1089-96. PubMed ID: 23093373
[TBL] [Abstract][Full Text] [Related]
12. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.
Kurdi M; De Mello WC; Booz GW
Int J Biochem Cell Biol; 2005 Jul; 37(7):1357-67. PubMed ID: 15833268
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
Seki N; Hashimoto N; Suzuki Y; Yagui K; Saito Y
Diabetes Res Clin Pract; 2006 May; 72(2):135-41. PubMed ID: 16290123
[TBL] [Abstract][Full Text] [Related]
14. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
15. Effects of angiotensin II receptor blockers on dementia.
Mogi M; Horiuchi M
Hypertens Res; 2009 Sep; 32(9):738-40. PubMed ID: 19727113
[TBL] [Abstract][Full Text] [Related]
16. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular angiotensin AT1 receptor regulation in cerebral ischemia.
Edvinsson L
Trends Cardiovasc Med; 2008 Apr; 18(3):98-103. PubMed ID: 18436148
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.
Kohlstedt K; Gershome C; Trouvain C; Hofmann WK; Fichtlscherer S; Fleming I
Mol Pharmacol; 2009 Mar; 75(3):685-92. PubMed ID: 19114589
[TBL] [Abstract][Full Text] [Related]
19. Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation.
Grote K; Ortmann M; Salguero G; Doerries C; Landmesser U; Luchtefeld M; Brandes RP; Gwinner W; Tschernig T; Brabant EG; Klos A; Schaefer A; Drexler H; Schieffer B
Cardiovasc Res; 2006 Aug; 71(3):596-605. PubMed ID: 16843452
[TBL] [Abstract][Full Text] [Related]
20. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
